CAR-T Drugs' Patient-Reported Outcomes To Be Focus Of MedCAC Meeting

Focus is in line with past US Medicare advisory panel meetings on other diseases.

The Centers for Medicare and Medicaid Services’ Medicare Evidence Development & Coverage Advisory Committee (MedCAC) will review evidence specific to patient reported outcomes during its Aug. 22 meeting on CAR-T drugs, the agency recently announced.

“We are seeking recommendations from MedCAC panel regarding how existing PRO assessment tools should be incorporated into future clinical studies,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers